Role of Chromogranin A-derived Fragments as Biomarkers for Pancreatic Neuroendocrine Tumors (PanNET)

被引:0
|
作者
Andreasi, V. [1 ,2 ]
Partelli, S. [1 ]
Manzoni, M. [3 ]
Colombo, B. [2 ]
Muffatti, F. [1 ]
Corti, A. [2 ]
Falconi, M. [1 ]
机构
[1] Univ Vita Salute San Raffaele, Pancreat Surg Unit, Pancreas Translat & Clin Res Ctr, Milan, Italy
[2] Univ Vita Salute San Raffaele, Tumor Biol & Vasc Targeting Unit, Expt Oncol, Milan, Italy
[3] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, IRCCS, Endocrinol Unit, Milan, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
O-8
引用
收藏
页码:465 / 466
页数:2
相关论文
共 50 条
  • [11] The Role of Chromogranin A as a Predictor of Radiological Disease Progression in Midgut and Pancreatic Neuroendocrine Tumors
    Rossi, R. E.
    Garcia-Hernandez, J.
    Martin, N. G.
    Mohmaduves, M.
    Meyer, T.
    Thirlwell, C.
    Watkins, J.
    Caplin, M.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 257 - 258
  • [12] Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors
    Shanahan, Matthew A.
    Salem, Ahmed
    Fisher, Alexander
    Cho, Clifford S.
    Leverson, Glen
    Winslow, Emily R.
    Weber, Sharon M.
    JOURNAL OF SURGICAL RESEARCH, 2016, 201 (01) : 38 - 43
  • [13] Prognostic Significance of Chromogranin A in Small Pancreatic Neuroendocrine Tumors
    Raoof, M.
    Jutric, Z.
    Melstrom, L.
    Warner, S.
    Woo, Y.
    Fong, Y.
    Singh, G.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S122 - S123
  • [14] Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors
    Raoof, Mustafa
    Jutric, Zeljka
    Melstrom, Laleh G.
    Lee, Byrne
    Li, Daneng
    Warner, Susanne G.
    Fong, Yuman
    Singh, Gagandeep
    SURGERY, 2019, 165 (04) : 760 - 766
  • [15] DISTRIBUTION AND CHARACTERIZATION OF THE CHROMOGRANIN A-DERIVED PEPTIDE, WE-14, IN RAT NEUROENDOCRINE TISSUES
    CURRY, WJ
    JOHNSTON, CF
    SHAW, C
    BUCHANAN, KD
    REGULATORY PEPTIDES, 1992, 40 (02) : 129 - 129
  • [16] Biomarkers in pancreatic neuroendocrine tumors.
    Alistar, Angela Tatiana
    Warner, Richard
    Moshier, Erin
    Kim, Michelle
    Holcombe, Randall F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [17] Biomarkers for prognosis in pancreatic neuroendocrine tumors
    Zhu, Mojun
    Sorenson, Karl R.
    Liu, Rebecca
    Rothberg, Bonnie E. Gould
    Halfdanarson, Thorvardur R.
    ENDOCRINE-RELATED CANCER, 2021, 28 (12) : 773 - 782
  • [18] Prognostic biomarkers in pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    VandenBussche, Christopher J.
    CANCER CYTOPATHOLOGY, 2021, 129 (11) : 841 - 843
  • [19] Evaluating the significance of Chromogranin A and Synaptophysin in Pancreatic Neuroendocrine Tumors. A road towards finding independent biomarkers
    Fatima, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 107 - 107
  • [20] Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors
    Miki, Masami
    Ito, Tetsuhide
    Hijioka, Masayuki
    Lee, Lingaku
    Yasunaga, Kohei
    Ueda, Keijiro
    Fujiyama, Takashi
    Tachibana, Yuichi
    Kawabe, Ken
    Jensen, Robert T.
    Ogawa, Yoshihiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (06) : 520 - 528